This dynamic nuclear-cytoplasmic distribution strongly correlates with tumor malignancy and metastatic potential, suggesting VIRMA localization may serve as a potential tumor grading biomarker [19,23,24]. The gene discussed is VIRMA; the disease is neoplasm.